Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Moore

Showing results (41-50 of 500) with videos related to

Pageof 50
Sort By:
BMC Health Services Research|November 27, 2013
Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group studyAnne K Monroe, Tashi L Rowe, Richard D Moore, et al.
AIDS (London, England)|June 12, 2003
Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settingsLisa A Spacek, Michael Griswold, Thomas C Quinn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy eraKelly A Gebo, Rita Kalyani, Richard D Moore, et al.
Statistics in Medicine|April 18, 2008
Evaluating competing adverse and beneficial outcomes using a mixture modelBryan Lau, Stephen R Cole, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2007
Immune reconstitution inflammatory syndrome: risk factors and treatment implicationsYukari C Manabe, James D Campbell, Emily Sydnor, et al.
AIDS (London, England)|June 18, 2016
A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDUCatherine R Lesko, Jessie K Edwards, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative studyGregory M Lucas, Paul J Weidle, Shannon Hader, et al.
Antiviral Therapy|January 25, 2014
Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or CChristopher B Hurt, Sonia Napravnik, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 18, 2013
Higher quality communication and relationships are associated with improved patient engagement in HIV careTabor E Flickinger, Somnath Saha, Richard D Moore, et al.
Epidemiology (Cambridge, Mass.)|August 9, 2019
Censoring for Loss to Follow-up in Time-to-event Analyses of Composite Outcomes or in the Presence of Competing RisksCatherine R Lesko, Jessie K Edwards, Richard D Moore, et al.
Pageof 50

Showing results (41-50 of 500) with videos related to

Sort By:
Pageof 50
BMC Health Services Research|November 27, 2013
Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group studyAnne K Monroe, Tashi L Rowe, Richard D Moore, et al.
AIDS (London, England)|June 12, 2003
Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settingsLisa A Spacek, Michael Griswold, Thomas C Quinn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy eraKelly A Gebo, Rita Kalyani, Richard D Moore, et al.
Statistics in Medicine|April 18, 2008
Evaluating competing adverse and beneficial outcomes using a mixture modelBryan Lau, Stephen R Cole, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2007
Immune reconstitution inflammatory syndrome: risk factors and treatment implicationsYukari C Manabe, James D Campbell, Emily Sydnor, et al.
AIDS (London, England)|June 18, 2016
A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDUCatherine R Lesko, Jessie K Edwards, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative studyGregory M Lucas, Paul J Weidle, Shannon Hader, et al.
Antiviral Therapy|January 25, 2014
Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or CChristopher B Hurt, Sonia Napravnik, Richard D Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 18, 2013
Higher quality communication and relationships are associated with improved patient engagement in HIV careTabor E Flickinger, Somnath Saha, Richard D Moore, et al.
Epidemiology (Cambridge, Mass.)|August 9, 2019
Censoring for Loss to Follow-up in Time-to-event Analyses of Composite Outcomes or in the Presence of Competing RisksCatherine R Lesko, Jessie K Edwards, Richard D Moore, et al.
Pageof 50